Hybrigenics S.A.
Records under this name other than the patents Hybrigenics S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,481,514 | Therapeutical uses of inecalcitol Lapsed on the fee record Ended Jul 9, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 9, 2025 | From the USPTO record |
| US 9,546,150 | Substituted quinazolin-4-ones for inhibiting ubiquitin specific protease 7 Lapsed on the fee record Ended Jan 17, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jan 17, 2025 | From the USPTO record |
| US 9,315,455 | Process for isomerizing fused bicyclic structures and preparation of vitamin D analogs comprising the same Lapsed on the fee record Ended Apr 19, 2024 · From the USPTO record | Lapsed on the fee record | Ended Apr 19, 2024 | From the USPTO record |
| US 7,875,613 | Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications Lapsed on the fee record Ended Jan 25, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jan 25, 2023 | From the USPTO record |
| US 10,111,896 | Composition Comprising a Combination of DNA Methylation Inhibitor and a Vitamin D Receptor Agonist for the Treatment of Drug Resistant Cancer or for the Prevention of Tumor Relapse Lapsed on the fee record Ended Oct 30, 2022 · High confidence | Lapsed on the fee record | Ended Oct 30, 2022 | High confidence |
| US 7,763,254 | Human Immunodeficiency Virus Integrase-Ledgf P75 Isoform Protein-Protein Interactions. Formerly held Lapsed on the fee record Ended Jul 27, 2022 · High confidence | Lapsed on the fee record | Ended Jul 27, 2022 | High confidence |
| US 8,648,076 | Cysteine protease inhibitors and their therapeutic applications Lapsed on the fee record Ended Feb 11, 2022 · From the USPTO record | Lapsed on the fee record | Ended Feb 11, 2022 | From the USPTO record |
| US 7,462,615 | Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications Lapsed on the fee record Ended Dec 9, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 9, 2020 | From the USPTO record |
| US 6,916,615 | Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof Term ended Term ended Jul 3, 2020 · From the USPTO record | Term ended | Term ended Jul 3, 2020 | From the USPTO record |
| US 9,328,093 | Selective inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications Lapsed on the fee record Ended May 3, 2020 · From the USPTO record | Lapsed on the fee record | Ended May 3, 2020 | From the USPTO record |